Alimta Sales Data

Rank 43 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Alimta U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 43 (3) 6.00% 7.94%
Q3 2013 46 (4) -5.87% -5.50%
Q2 2013 42 (7) 10.84% 11.73%
Q1 2013 49 (8) -8.17% -9.60%
Q4 2012 41 (6) 7.89% 8.79%
Q3 2012 47 (3) -1.39% -2.67%
Q2 2012 50 (9) 6.53% 7.47%
Q1 2012 59 (1) 1.24% -0.57%
Q4 2011 60 (2) 1.82% 3.55%
Q3 2011 58 (5) 1.37% -0.59%
Q2 2011 63 (4) 3.76% 4.29%
Q1 2011 67

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
June 5, 2011Taking Chemo Drug Continuously Delayed Lung Cancer's Return
May 30, 2009Drug Trials Show Modest Gains Against Lung Cancer
Hide
(web5)